Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol

Kwang-Hoon Song1, Tiangang Li, Erika Owsley

  • 1Department of Integrative Medical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Rootstown, OH 44272, USA.

Hepatology (Baltimore, Md.)
|December 17, 2008
PubMed
Abstract

Insights

Bile acids induce fibroblast growth factor 19 (FGF19) in liver cells, which then inhibits bile acid synthesis by activating the FGF receptor 4 (FGFR4) and Erk1/2 pathway, independent of SHP. This pathway prevents toxic bile acid buildup in human livers.

Area of Science:

  • Hepatology
  • Endocrinology
  • Molecular Biology

Background:

  • Fibroblast growth factor 15 (FGF15) and its human ortholog FGF19 are bile acid-induced intestinal factors.
  • FGF15/FGF19 mediate feedback inhibition of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription in mouse liver.
  • The precise mechanism of FGF15/FGF19 in inhibiting bile acid synthesis in hepatocytes remains unclear.

Purpose of the Study:

  • To elucidate the mechanism by which FGF19 inhibits bile acid synthesis in human hepatocytes.
  • To investigate the role of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MAPK/Erk1/2) pathway and FGF receptor 4 (FGFR4) in FGF19 signaling.

Main Methods:

  • Primary human hepatocytes were treated with chenodeoxycholic acid (CDCA) or a farnesoid X receptor (FXR) agonist.
  • Messenger RNA (mRNA) levels of CYP7A1 and small heterodimer partner (SHP) were measured.
  • Kinase inhibition, phosphorylation assays, siRNA knockdown, and antibody neutralization were employed to study signaling pathways.

Main Results:

  • CDCA and the FXR agonist induced FGF19 and inhibited CYP7A1 mRNA levels in hepatocytes.
  • FGF19 rapidly repressed CYP7A1 mRNA but not SHP mRNA.
  • The MAPK/Erk1/2 pathway was crucial for FGF19-mediated CYP7A1 inhibition.
  • CDCA stimulated tyrosine phosphorylation of FGFR4, and FGFR4 inhibition abrogated FGF19's effect on CYP7A1.

Conclusions:

  • Hepatic FGF19 signaling via FGFR4 and Erk1/2 inhibits CYP7A1 independently of SHP.
  • Bile acids activate an autocrine/paracrine FGF19/FGFR4/Erk1/2 pathway in hepatocytes.
  • This pathway serves to inhibit bile acid synthesis and prevent the accumulation of toxic bile acids in human livers.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...